Yuanna Ling
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuanna Ling has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Aihua Chen
Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, People’s Republic of China
2 shared publications Haiqiong Liu
Southern Medical University, China; Southern Medical University, China
2 shared publicationsJing Yan
Southern Medical University, China; Southern Medical University, China
2 shared publicationsXiheng Mei
Southern Medical University, China; Southern Medical University, China
2 shared publicationsChaobo Yang
Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, Guangdong, China; Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangdong, China; Guangdong Provincial Key Laboratory of Shock and Microcirculation, Southern Medical University, Guangdong, China
1 shared publicationDaojun Wen
Department of Cardiology, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 59, e211035
Compound Danshen Dripping Pills pretreatment protects the heart from ischemia/reperfusion injury by enhancing autophagic flux
Compound Danshen Dripping Pills (CDDPs) have been used in clinical treatment to protect the heart from ischemia/reperfusion (IR) injury for many years. However, the underlying mechanism implicated in the protective effects remains to be explored. Here, we determined the effects of CDDPs in Sprague-Dawley rats with the IR model. Cardiac function in vivo was assessed by echocardiography. Transmission electron microscopy, histological and immunohistochemical techniques, Western blotting and recombinant adeno-associated virus 9 transfection were used to illustrate the effects of CDDPs on IR and autophagy. Our results showed that pretreatment with CDDPs decreased the level of serum myocardial enzymes and infarct size in rats after IR. Apoptosis evaluation showed that CDDPs significantly ameliorated the cardiac apoptosis level after IR. Meanwhile, CDDPs pretreatment increased myocardial autophagic flux, with upregulation of LC3B, downregulation of p62, and increased autophagosomes and autolysosomes. Moreover, the autophagic flux inhibitor chloroquine could increase IR injury, while CDDPs could partially reverse the effects. Furthermore, our results showed that the activation of AMPK/mTOR was involved in the cardioprotective effect exerted by CDDPs. Herein, we suggest that CDDPs partially protect the heart from IR injury by enhancing autophagic flux through the activation of AMPK/mTOR.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 59, e211035
Open AccessCompound Danshen Dripping Pills pretreatment protects the heart from ischemia/reperfusion injury by enhancing autophagic flux
Compound Danshen Dripping Pills (CDDPs) have been used in clinical treatment to protect the heart from ischemia/reperfusion (IR) injury for many years. However, the underlying mechanism implicated in the protective effects remains to be explored. Here, we determined the effects of CDDPs in Sprague-Dawley rats with the IR model. Cardiac function in vivo was assessed by echocardiography. Transmission electron microscopy, histological and immunohistochemical techniques, Western blotting and recombinant adeno-associated virus 9 transfection were used to illustrate the effects of CDDPs on IR and autophagy. Our results showed that pretreatment with CDDPs decreased the level of serum myocardial enzymes and infarct size in rats after IR. Apoptosis evaluation showed that CDDPs significantly ameliorated the cardiac apoptosis level after IR. Meanwhile, CDDPs pretreatment increased myocardial autophagic flux, with upregulation of LC3B, downregulation of p62, and increased autophagosomes and autolysosomes. Moreover, the autophagic flux inhibitor chloroquine could increase IR injury, while CDDPs could partially reverse the effects. Furthermore, our results showed that the activation of AMPK/mTOR was involved in the cardioprotective effect exerted by CDDPs. Herein, we suggest that CDDPs partially protect the heart from IR injury by enhancing autophagic flux through the activation of AMPK/mTOR.
- 14 July 2022
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 189, 122-135
A novel function of ATF3 in suppression of ferroptosis in mouse heart suffered ischemia/reperfusion
- 14 July 2022
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 189, 122-135
A novel function of ATF3 in suppression of ferroptosis in mouse heart suffered ischemia/reperfusion